MSI-HIGH
Clinical trials for MSI-HIGH explained in plain language.
Never miss a new study
Get alerted when new MSI-HIGH trials appear
Sign up with your email to follow new studies for MSI-HIGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could boost immunotherapy for tough cancers
Disease control Recruiting nowThis study tests an experimental oral drug called 7HP349 (Alintegimod) taken with standard immunotherapy drugs (ipilimumab and nivolumab) for people with advanced solid tumors like melanoma, lung, kidney, or liver cancer who have already tried other treatments. The goal is to see…
Matched conditions: MSI-HIGH
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called 177Lu-RAD204, which is a radioactive antibody designed to seek out and attack cancer cells. About 30 adults with advanced solid tumors (like lung, breast, or skin cancer) that have not responded to other treatments will receive the d…
Matched conditions: MSI-HIGH
Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Jun 08, 2026 13:18 UTC